Terms: = Thyroid cancer AND CALR, ENSG00000179218, 811, P27797, SSA, RO, FLJ26680, cC1qR AND Clinical Outcome
2 results:
1. Development and validation of an individualized nomogram for predicting the high-volume (> 5) central lymph node metastasis in papillary thyroid microcarcinoma.
Wei X; Min Y; Feng Y; He D; Zeng X; Huang Y; Fan S; Chen H; Chen J; Xiang K; Luo H; Yin G; Hu D
J Endocrinol Invest; 2022 Mar; 45(3):507-515. PubMed ID: 34491546
[TBL] [Abstract] [Full Text] [Related]
2. clinical outcome and evidence of high rate post-surgical anterior hypopituitarism in a cohort of TSH-secreting adenoma patients: Might somatostatin analogs have a role as first-line therapy?
Gatto F; Grasso LF; Nazzari E; Cuny T; Anania P; Di Somma C; Colao A; Zona G; Weryha G; Pivonello R; Ferone D
Pituitary; 2015 Oct; 18(5):583-91. PubMed ID: 25326851
[TBL] [Abstract] [Full Text] [Related]
